CERo Therapeutics Holdings, Inc. (CEROW) NASDAQ
$0.01 (0) (-33.00%)
Market Cap: $339376
As of 09/12/24 04:00 PM EDT. Market open.
CERo Therapeutics Holdings, Inc. (CEROW)
NASDAQ
$0.01
(0) (-33.00%)
Market Cap: $339376
As of 09/12/24 04:00 PM EDT. Market open.
Add to Portfolio
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Brian G. Atwood
Full Time Employees
8
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Brian G. Atwood
Full Time Employees
8
URL
Address
201 Haskins Way, CA, South San Francisco, 94080.
PRICE CHART FOR CERO THERAPEUTICS HOLDINGS, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.01
Previous Close
$0.01
Days Range
$0.01 - $0.01
52 week range
$0.01 - $0.01
Volume
64,580
Avg. Volume (30 days)
0
Market Cap
$339376
Dividend Yield
-
P/E
-
Shares Outstanding
50,653,138
Open
$0.01
Previous Close
$0.01
Days Range
$0.01 - $0.01
52 week range
$0.01 - $0.01
Volume
64,580
Avg. Volume (30 days)
0
Market Cap
$339376
Dividend Yield
-
P/E
-
Shares Outstanding
50,653,138
FINANCIAL STATEMENTS FOR CERO THERAPEUTICS HOLDINGS, INC.
LOADING...
FUNDS WITH A POSITION IN CERO THERAPEUTICS HOLDINGS, INC.
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
NEXPOINT ASSET MANAGEMENT, L.P. | 108,741 | 0.00028% | No change | Event Driven, Value |
WESTCHESTER CAPITAL MANAGEMENT, LLC | 74,998 | 0.00006% | No change | Event Driven |
DUPONT CAPITAL MANAGEMENT CORP | 12,500 | 0.00002% | No change | Other |
BUYBACK ANNOUNCEMENT(S) FOR CERO THERAPEUTICS HOLDINGS, INC.
LOADING...